Abstract
The purpose of the present study was to define the role of mesenchymal stem cell (MSC)–derived extracellular vesicles (EVs) in the progression of myocardial infarction (MI)–induced cardiac fibrosis. An in vitro cell model of hypoxia-induced cardiac fibrosis was constructed in cardiac fibroblasts (CFs). miR-212-5p was poorly expressed in clinical pathological samples and animal models of cardiac fibrosis caused by MI, while miR-212-5p expression was enriched in EVs released from MSCs. EVs from MSCs were isolated, evaluated, and co-cultured with CFs. Dual-luciferase reporter gene assay revealed that miR-212-5p negatively targeted NLRC5 progression of cardiac fibrosis. Following loss- and gain-function assay, EVs expressing miR-212-5p protected against cardiac fibrosis evidenced by reduced levels of α-SMA, Collagen I, TGF-β1, and IL-1β. In vivo experiments further confirmed the above research results. Collectively, EVs from MSCs expressing miR-212-5p may attenuate MI by suppressing the NLRC5/VEGF/TGF-β1/SMAD axis.
Similar content being viewed by others
Abbreviations
- MSCs:
-
Mesenchymal stem cells
- EVs:
-
Extracellular vesicles
- MI:
-
Myocardial infarction
- CFs:
-
Cardiac fibroblasts
- MI:
-
Myocardial infarction
- SPF:
-
Specific pathogen free
- DMEM:
-
Dulbecco’s modified eagle medium
- FITC:
-
Fluorescein isothiocyanate
- PE:
-
Polyethylene
- NC:
-
Negative control
- BSA:
-
Bull serum albumin
- ECG:
-
Echocardiogram
- LVIDs:
-
Left ventricular inner systolic diameter
- LVESV:
-
Left ventricular systolic volume
References
Gou, L., Xue, C., Tang, X., & Fang, Z. (2020). Inhibition of Exo-miR-19a-3p derived from cardiomyocytes promotes angiogenesis and improves heart function in mice with myocardial infarction via targeting HIF-1alpha. Aging, 12(23), 23609–23618. https://doi.org/10.18632/aging.103563(Albany NY).
Mihalko, E., Huang, K., Sproul, E., Cheng, K., & Brown, A. C. (2018). Targeted treatment of ischemic and fibrotic complications of myocardial infarction using a dual-delivery microgel therapeutic. ACS Nano, 12(8), 7826–7837. https://doi.org/10.1021/acsnano.8b01977.
Cui, S., Liu, Z., Tao, B., Fan, S., Pu, Y., Meng, X., et al. (2021). miR-145 attenuates cardiac fibrosis through the AKT/GSK-3beta/beta-catenin signaling pathway by directly targeting SOX9 in fibroblasts. Journal of Cellular Biochemistry, 122(2), 209–221. https://doi.org/10.1002/jcb.29843.
Han, C., Zhou, J., Liang, C., Liu, B., Pan, X., Zhang, Y., et al. (2019). Human umbilical cord mesenchymal stem cell derived exosomes encapsulated in functional peptide hydrogels promote cardiac repair. Biomaterials Science, 7(7), 2920–2933. https://doi.org/10.1039/c9bm00101h.
Park, S., Nguyen, N. B., Pezhouman, A., & Ardehali, R. (2019). Cardiac fibrosis: potential therapeutic targets. Translational Research, 209, 121–137. https://doi.org/10.1016/j.trsl.2019.03.001.
Wang, Z., Fu, M., & Li, Y. (2020). miR-142-5p and miR-212-5p cooperatively inhibit the proliferation and collagen formation of cardiac fibroblasts by regulating c-Myc/TP53INP1. Canadian Journal of Physiology and Pharmacology, 98(5), 314–323. https://doi.org/10.1139/cjpp-2019-0495.
Xue, Y., Fan, X., Yang, R., Jiao, Y., & Li, Y. (2020). miR-29b-3p inhibits post-infarct cardiac fibrosis by targeting FOS. Biosci Rep, 40(9). https://doi.org/10.1042/BSR20201227.
Hillman, Y., Mardamshina, M., Pasmanik-Chor, M., Ziporen, L., Geiger, T., Shomron, N., et al. (2019). MicroRNAs affect complement regulator expression and mitochondrial activity to modulate cell resistance to complement-dependent cytotoxicity. Cancer Immunology Research, 7(12), 1970–1983. https://doi.org/10.1158/2326-6066.CIR-18-0818.
Yang, Y., Cai, Y., Zhang, Y., Liu, J., & Xu, Z. (2018). Exosomes secreted by adipose-derived stem cells contribute to angiogenesis of brain microvascular endothelial cells following oxygen-glucose deprivation in vitro through microRNA-181b/TRPM7 axis. Journal of Molecular Neuroscience, 65(1), 74–83. https://doi.org/10.1007/s12031-018-1071-9.
Ren, N., & Wang, M. (2018). microRNA-212-induced protection of the heart against myocardial infarction occurs via the interplay between AQP9 and PI3K/Akt signaling pathway. Experimental Cell Research, 370(2), 531–541. https://doi.org/10.1016/j.yexcr.2018.07.018.
Spence, D. W., & Stewart, W. D. (1986). Proline inhibits N2-fixation in Anabaena 7120. Biochemical and Biophysical Research Communications, 139(3), 940–946. https://doi.org/10.1016/s0006-291x(86)80268-6.
He, Y. H., Li, M. F., Zhang, X. Y., Meng, X. M., Huang, C., & Li, J. (2016). NLRC5 promotes cell proliferation via regulating the AKT/VEGF-A signaling pathway in hepatocellular carcinoma. Toxicology, 359-360, 47–57. https://doi.org/10.1016/j.tox.2016.06.012.
Melincovici, C. S., Bosca, A. B., Susman, S., Marginean, M., Mihu, C., Istrate, M., et al. (2018). Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Romanian Journal of Morphology and Embryology, 59(2), 455–467.
Wilmes, V., Lux, C., Niess, C., Gradhand, E., Verhoff, M. A., & Kauferstein, S. (2020). Changes in gene expression patterns in postmortem human myocardial infarction. International Journal of Legal Medicine, 134(5), 1753–1763. https://doi.org/10.1007/s00414-020-02311-2.
Borger, V., Bremer, M., Ferrer-Tur, R., Gockeln, L., Stambouli, O., Becic, A., et al. (2017). Mesenchymal stem/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents. International Journal of Molecular Sciences, 18(7). https://doi.org/10.3390/ijms18071450.
Zhao, Y., Sun, X., Cao, W., Ma, J., Sun, L., Qian, H., et al. (2015). Exosomes derived from human umbilical cord mesenchymal stem cells relieve acute myocardial ischemic injury. Stem Cells International, 2015, 761643. https://doi.org/10.1155/2015/761643.
Liu, Z., Liu, J., Wei, Y., Xu, J., Wang, Z., Wang, P., et al. (2020). LncRNA MALAT1 prevents the protective effects of miR-125b-5p against acute myocardial infarction through positive regulation of NLRC5. Experimental and Therapeutic Medicine, 19(2), 990–998. https://doi.org/10.3892/etm.2019.8309.
Zhou, H., Yu, X., & Zhou, G. (2017). NLRC5 silencing ameliorates cardiac fibrosis by inhibiting the TGFbeta1/Smad3 signaling pathway. Molecular Medicine Reports, 16(3), 3551–3556. https://doi.org/10.3892/mmr.2017.6990.
Park, H. Y., Kim, J. H., & Park, C. K. (2013). VEGF induces TGF-beta1 expression and myofibroblast transformation after glaucoma surgery. The American Journal of Pathology, 182(6), 2147–2154. https://doi.org/10.1016/j.ajpath.2013.02.009.
Gao, H., Bo, Z., Wang, Q., Luo, L., Zhu, H., & Ren, Y. (2019). Salvanic acid B inhibits myocardial fibrosis through regulating TGF-beta1/Smad signaling pathway. Biomedicine & Pharmacotherapy, 110, 685–691. https://doi.org/10.1016/j.biopha.2018.11.098.
Shi, Y., Lin, P., Wang, X., Zou, G., & Li, K. (2018). Sphingomyelin phosphodiesterase 1 (SMPD1) mediates the attenuation of myocardial infarction-induced cardiac fibrosis by astaxanthin. Biochemical and Biophysical Research Communications, 503(2), 637–643. https://doi.org/10.1016/j.bbrc.2018.06.054.
Weng, L., Jia, S., Xu, C., Ye, J., Cao, Y., Liu, Y., et al. (2018). Nogo-C regulates post myocardial infarction fibrosis through the interaction with ER Ca(2+) leakage channel Sec61alpha in mouse hearts. Cell Death & Disease, 9(6), 612. https://doi.org/10.1038/s41419-018-0598-6.
Hao, K., Lei, W., Wu, H., Wu, J., Yang, Z., Yan, S., et al. (2019). LncRNA-Safe contributes to cardiac fibrosis through Safe-Sfrp2-HuR complex in mouse myocardial infarction. Theranostics, 9(24), 7282–7297. https://doi.org/10.7150/thno.33920.
Kang, S. C., Sohn, E. H., & Lee, S. R. (2020). Hydrogen sulfide as a potential alternative for the treatment of myocardial fibrosis. Oxidative Medicine and Cellular Longevity, 2020, 4105382. https://doi.org/10.1155/2020/4105382.
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016). Cardiac extracellular vesicles in normal and infarcted heart. International Journal of Molecular Sciences, 17(1). https://doi.org/10.3390/ijms17010063.
Sahoo, S., & Losordo, D. W. (2014). Exosomes and cardiac repair after myocardial infarction. Circulation Research, 114(2), 333–344. https://doi.org/10.1161/CIRCRESAHA.114.300639.
Gong, X. H., Liu, H., Wang, S. J., Liang, S. W., & Wang, G. G. (2019). Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction. Journal of Cellular Physiology, 234(8), 13878–13893. https://doi.org/10.1002/jcp.28070.
Harrell, C. R., Fellabaum, C., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019). Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells, 8(5). https://doi.org/10.3390/cells8050467.
Tan, S. J. O., Floriano, J. F., Nicastro, L., Emanueli, C., & Catapano, F. (2020). Novel applications of mesenchymal stem cell-derived exosomes for myocardial infarction therapeutics. Biomolecules, 10(5). https://doi.org/10.3390/biom10050707.
Bang, C., Batkai, S., Dangwal, S., Gupta, S. K., Foinquinos, A., Holzmann, A., et al. (2014). Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. The Journal of Clinical Investigation, 124(5), 2136–2146. https://doi.org/10.1172/JCI70577.
Wang, Y., Zhang, L., Li, Y., Chen, L., Wang, X., Guo, W., et al. (2015). Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. International Journal of Cardiology, 192, 61–69. https://doi.org/10.1016/j.ijcard.2015.05.020.
Chen, P., Wu, R., Zhu, W., Jiang, Z., Xu, Y., Chen, H., et al. (2014). Hypoxia preconditioned mesenchymal stem cells prevent cardiac fibroblast activation and collagen production via leptin. PLoS One, 9(8), e103587. https://doi.org/10.1371/journal.pone.0103587.
Eid, R. A., Khalil, M. A., Alkhateeb, M. A., Eleawa, S. M., Zaki, M. S. A., El-Kott, A. F., et al. (2020). Exendin-4 attenuates remodeling in the remote myocardium of rats after an acute myocardial infarction by activating beta-arrestin-2, protein phosphatase 2A, and glycogen synthase kinase-3 and inhibiting beta-catenin. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-020-07006-9.
Youssef, M. E., El-Mas, M. M., Abdelrazek, H. M., & El-Azab, M. F. (2021). alpha7-nAChRs-mediated therapeutic angiogenesis accounts for the advantageous effect of low nicotine doses against myocardial infarction in rats. European Journal of Pharmacology, 898, 173996. https://doi.org/10.1016/j.ejphar.2021.173996.
Wang, B., Wu, Y., Ge, Z., Zhang, X., Yan, Y., & Xie, Y. (2020). NLRC5 deficiency ameliorates cardiac fibrosis in diabetic cardiomyopathy by regulating EndMT through Smad2/3 signaling pathway. Biochemical and Biophysical Research Communications, 528(3), 545–553. https://doi.org/10.1016/j.bbrc.2020.05.151.
Wang, D. M., Jin, J. J., Tian, L. M., & Zhang, Z. (2020). MiR-195 promotes myocardial fibrosis in MI rats via targeting TGF-beta1/Smad. Journal of Biological Regulators and Homeostatic Agents, 34(4), 1325–1332. https://doi.org/10.23812/20-201-A.
Chen, G., Huang, S., Song, F., Zhou, Y., & He, X. (2020). Lnc-Ang362 is a pro-fibrotic long non-coding RNA promoting cardiac fibrosis after myocardial infarction by suppressing Smad7. Archives of Biochemistry and Biophysics, 685, 108354. https://doi.org/10.1016/j.abb.2020.108354.
Lin, Y., Zhang, F., Lian, X. F., Peng, W. Q., & Yin, C. Y. (2019). Mesenchymal stem cell-derived exosomes improve diabetes mellitus-induced myocardial injury and fibrosis via inhibition of TGF-beta1/Smad2 signaling pathway. Cellular and Molecular Biology (Noisy-le-Grand, France), 65(7), 123–126.
Pan, J., Alimujiang, M., Chen, Q., Shi, H., & Luo, X. (2019). Exosomes derived from miR-146a-modified adipose-derived stem cells attenuate acute myocardial infarction-induced myocardial damage via downregulation of early growth response factor 1. Journal of Cellular Biochemistry, 120(3), 4433–4443. https://doi.org/10.1002/jcb.27731.
Funding
This work was supported by the Medical Scientific Research Foundation of Guangdong Province (No. A2020002) and the Science and Technology Program of Guangzhou, China (No. 202102080011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Associate Editor Junjie Xiao oversaw the review of this article
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Figure S1
Western blots. A, NLRC5, α-SMA and VEGF protein expression in cells tested by western blot analysis. B, The expression of p-SMAD2/3, NLRC5 and VEGF in anti-miR-212-5p and GW4869 groups detected by western blot analysis.) (PNG 5043 kb)
Figure S2
MSCs-derived EVs deliver miR-212-5p to alleviate MI. A, TTC staining of the heart tissues. B, Statistics of TTC staining results. C, The serum cTnT level detected using ELISA (***p < 0.05 vs. the sham group; ###p < 0.05 vs. the MI group; &&&p < 0.05 vs. the MI-EVs-NC group). n = 8 in each group of mice. Measurement data were expressed by mean ± standard deviation. One-way ANOVA was used for multiple group comparisons, followed by Tukey's post hoc test. (PNG 2633 kb)
ESM 3
(DOCX 20 kb)
Rights and permissions
About this article
Cite this article
Wu, Y., Peng, W., Fang, M. et al. MSCs-Derived Extracellular Vesicles Carrying miR-212-5p Alleviate Myocardial Infarction-Induced Cardiac Fibrosis via NLRC5/VEGF/TGF-β1/SMAD Axis. J. of Cardiovasc. Trans. Res. 15, 302–316 (2022). https://doi.org/10.1007/s12265-021-10156-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-021-10156-2